Luthringer Remy's most recent trade in Minerva Neurosciences Inc was a trade of 2,250,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2025 | 2,250,000 | 2,250,000 | - | - | Employee Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Luthringer Remy | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 105,000 | 105,000 | - | - | Employee Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 88,077 | 96,388 (0%) | 0% | 0 | Common Stock | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 28 Apr 2023 | 23,753 | 72,635 (0%) | 0% | 3.8 | 91,449 | Common Stock |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Sale of securities on an exchange or to another person at price $ 3.76 per share. | 28 Apr 2023 | 3,641 | 68,994 (0%) | 0% | 3.8 | 13,690 | Common Stock |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 45,000 | 45,000 | - | - | Employee Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 505,000 | 505,000 | - | - | Employee Stock Option (right to buy) |